Apply for Funding
CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.
Learn more about the grants process.
Individual Investigator Research Awards for Prevention and Early Detection
Program | Academic Research |
RFA Status | Open |
Description |
Supports applications which propose clinical and population-based projects designed to develop effective prevention and early detection interventions to reduce cancer risk, mortality, and morbidity among Texans. Projects that propose such research collaborations with existing CPRIT Prevention Program awardees including the CPRIT funded Texas Collaborative Center for Hepatocellular Cancer (https://www.bcm.edu/research/labs-and-centers/research-centers/texas-collaborative-center-for-hepatocellular-cancer) and cancer survivorship research to enhance the health and well-being of all cancer survivors and caregivers, are strongly encouraged. Award: Up to $300,000 per year for a period of up to 4 years |
Review Cycle | Fiscal Year 2026 - Cycle 1 |
RFA Release | January 14, 2025 |
Application Receipt | February 18, 2025 - May 06, 2025 |
Application Review | May 2025 - November 2025 |
Award Notification | November 2025 |
Individual Investigator Research Awards for Early-Onset Cancers
Program | Academic Research |
RFA Status | Open |
Description |
Supports innovative research projects that will significantly advance the knowledge of the etiology, prevention, cancer biology, and treatment of early-onset cancers. Award: Up to $300,000 per year for period of up to 3 years |
Review Cycle | Fiscal Year 2026 - Cycle 1 |
RFA Release | January 14, 2025 |
Application Receipt | February 18, 2025 - May 06, 2025 |
Application Review | May 2025 - November 2025 |
Award Notification | November 2025 |
Individual Investigator Research Awards for Clinical Trials
Program | Academic Research |
RFA Status | Open |
Description |
Supports applications that propose innovative cancer clinical studies in adults or children and adolescents that are hypothesis driven and involve patients enrolled prospectively on a clinical trial. Areas of interest include clinical studies of new or repurposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices. Clinical trial must be planned to begin when contract is awarded. Award: Up to $400,000 per year for a period of up to 4 years |
Review Cycle | Fiscal Year 2026 - Cycle 1 |
RFA Release | January 14, 2025 |
Application Receipt | February 18, 2025 - May 06, 2025 |
Application Review | May 2025 - November 2025 |
Award Notification | November 2025 |
Individual Investigator Research Awards for Computational and Systems Biology of Cancer
Program | Academic Research |
RFA Status | Open |
Description |
Supports applications for innovative mathematical and/or computational research projects addressing questions that will advance current knowledge in the (a) mechanisms that tie altered gene expression and downstream molecular mechanisms to functional cancer phenotypes and/or (b) mechanisms that tie tumor morphology to functional cancer phenotypes and/or mechanisms that tie treatment sequence and combination to evolving functional cancer phenotypes (that emerge as a result of treatment selection). Award: Up to $350,000 per year for a period of up to 3 years |
Review Cycle | Fiscal Year 2026 - Cycle 1 |
RFA Release | January 14, 2025 |
Application Receipt | February 18, 2025 - May 06, 2025 |
Application Review | May 2025 - November 2025 |
Award Notification | November 2025 |
Individual Investigator Research Awards for Cancer in Children and Adolescents
Program | Academic Research |
RFA Status | Open |
Description |
Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable. CPRIT expects the outcome of the research to reduce the incidence, morbidity, or mortality from cancer in children and/or adolescents in the near- or long-term. Award: Up to $300,000 per year for a period of up to 4 years |
Review Cycle | Fiscal Year 2026 - Cycle 1 |
RFA Release | January 14, 2025 |
Application Receipt | February 18, 2025 - May 06, 2025 |
Application Review | May 2025 - November 2025 |
Award Notification | November 2025 |
Individual Investigator Research Awards
Program | Academic Research |
RFA Status | Open |
Description |
Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Areas of interest include laboratory research, translational studies, and/or clinical investigations. Award: Up to $300,000 per year for a period of up to 3 years |
Review Cycle | Fiscal Year 2026 - Cycle 1 |
RFA Release | January 14, 2025 |
Application Receipt | February 18, 2025 - May 06, 2025 |
Application Review | May 2025 - November 2025 |
Award Notification | November 2025 |
Recruitment of Established Investigators (REI)
Revised: 08/02/2024
Instructions for Applicants
Revised: 08/02/2024
Program | Academic Research |
RFA Status | Open |
Description |
Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas. Award: Up to $6 million over a period of five years. |
Review Cycle | Fiscal Year 2025 - Cycle 1 |
RFA Release | June 21, 2024 |
Application Receipt | June 21, 2024 - June 20, 2025 |
Application Review | September 2024 - July 2025 |
Award Notification | Continuous |
Recruitment of Rising Stars (RRS)
Revised: 08/02/2024
Instructions for Applicants
Revised: 08/02/2024
Program | Academic Research |
RFA Status | Open |
Description |
Recruits outstanding mid-level investigators to Texas, who have developed a track-record as an independent investigator and demonstrated the promise for continued and enhanced contributions to the field of cancer research. Award: Up to $4 million over a period of five years. |
Review Cycle | Fiscal Year 2025 - Cycle 1 |
RFA Release | June 21, 2024 |
Application Receipt | June 21, 2024 - June 20, 2025 |
Application Review | September 2024 - July 2025 |
Award Notification | Continuous |
Recruitment of First-Time, Tenure-Track Faculty Members (RFT)
Revised: 08/02/2024
Instructions for Applicants
Revised: 08/02/2024
Program | Academic Research |
RFA Status | Open |
Description |
Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research. Award: Up to $2 million up to a period of five years. |
Review Cycle | Fiscal Year 2025 - Cycle 1 |
RFA Release | June 21, 2024 |
Application Receipt | June 21, 2024 - June 20, 2025 |
Application Review | September 2024 - July 2025 |
Award Notification | Continuous |